Zobrazeno 1 - 10
of 58
pro vyhledávání: '"de Voer RM"'
Autor:
Khalid Mahmood, Chew E, Dagmara Dymerska, Roberts Aw, Mark Clendenning, Christoffer Flensburg, Nicoline Hoogerbrugge, Ben Kinnersley, Goldberg Y, Boris Noyvert, Jenny C. Taylor, Mathijs A. Sanders, van Wezel T, Lilian Vreede, Giulio Caravagna, Daniel D. Buchanan, Curley H, van der Biezen Sa, Richard S. Houlston, Celina Whalley, Michael Christie, Laura Chegwidden, Georgiou D, Judith E. Grolleman, Huw Thomas, Galavotti S, Sherwood K, Sottoriva A, Erik A. M. Jansen, Aleksandar Dimovski, Mark A. Jenkins, M.J.L. Ligtenberg, Roland P. Kuiper, Ian J. Majewski, Bajel A, Jakub Lubiński, Ian Tomlinson, Anna Frangou, Claire Palles, Pac Ca, Florentia Fostira, Deltas C, Clare Turnbull, Ingrid Winship, David N. Church, Lynn Martin, William Cross, Jürgen Weitz, David C. Wedge, Koelzer Vh, Rivas Ad, Barnes Ea, Nuria Lopez-Bigas, David J. Adams, van der Post Rs, Daniel Chubb, de Voer Rm, Trevor A. Graham, Andreas J. Gruber, Ponte Cr
Inherited defects in base-excision repair (BER) predispose to adenomatous polyposis and colorectal cancer (CRC), yet our understanding of this important DNA repair pathway remains incomplete. By combining detailed clinical, histological and molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0577ac58ac91b90d3d096b44b8aabcf
https://doi.org/10.1101/2021.04.27.441137
https://doi.org/10.1101/2021.04.27.441137
Autor:
Elze L; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., van der Post RS; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands., Vos JR; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Mensenkamp AR; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Pamidimarri Naga S; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherlands., Hampstead JE; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Vermeulen E; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Oorsprong M; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Hofste T; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Simons M; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands., Hoogerbrugge N; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., de Voer RM; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.; Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jul 03. Date of Electronic Publication: 2024 Jul 03.
Autor:
Hinić S; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., van der Post RS; Department of Pathology, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., Vreede L; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., Schuurs-Hoeijmakers J; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., Koene S; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., Jansen EAM; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., Bervoets-Metge F; Department of Pathology, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., Mensenkamp AR; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., Hoogerbrugge N; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., Ligtenberg MJL; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands.; Department of Pathology, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands., de Voer RM; Department of Human Genetics, Radboud University Medical Center, Research Institute for Medical Innovation, Nijmegen, The Netherlands.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Jul 01; Vol. 8 (4).
Autor:
Hinić S; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands., Van der Post RS; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Pathology, Nijmegen, The Netherlands., Vos JR; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands., Schuurs-Hoeijmakers J; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Brugnoletti F; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy., Koene S; Leiden University Medical Center, Department of Clinical Genetics, Leiden, The Netherlands., Vreede L; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., van Zelst-Stams WAG; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Kets CM; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Haadsma M; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Spruijt L; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Wevers MR; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Evans DG; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; The University of Manchester, Genomic Medicine, Division of Evolution, Infection and Genomic Sciences, Manchester, United Kingdom., Wimmer K; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Schnaiter S; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria., Volk AE; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Möllring A; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., de Putter R; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium., Soikkonen L; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Oulu University Hospital, Department of Clinical Genetics, Oulu, Finland., Kahre T; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Genetics and Personalized Medicine Clinic, Department of Laboratory Genetics, Tartu University Hospital, Tartu, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia., Tooming M; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Genetics and Personalized Medicine Clinic, Department of Laboratory Genetics, Tartu University Hospital, Tartu, Estonia; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia., de Jong MM; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands., Vaz F; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Instituto Português Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal., Mensenkamp AR; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands., Genuardi M; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Genomic Medicine, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy; Medical Genetics Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands., Ligtenberg M; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Pathology, Nijmegen, The Netherlands., Hoogerbrugge N; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands., de Voer RM; Radboud University Medical Center, Research Institute for Medical Innovation, Department of Human Genetics, Nijmegen, The Netherlands; European Reference Network for Genetic Tumour Risk Syndromes (ERN GENTURIS), Nijmegen, The Netherlands. Electronic address: richarda.devoer@radboudumc.nl.
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2024 May; Vol. 26 (5), pp. 101101. Date of Electronic Publication: 2024 Feb 13.
Autor:
Wijngaard R; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands., Demidov G; Universitätsklinikum Tübingen - Institut für Medizinische Genetik und angewandte Genomik, Tübingen, Germany., O'Gorman L; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Corominas-Galbany J; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Yaldiz B; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Steyaert W; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Boer E; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands., Vissers LELM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands., Kamsteeg EJ; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands., Pfundt R; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Swinkels H; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., den Ouden A; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Te Paske IBAW; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Voer RM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Faivre L; Centre de Référence Maladies Rares 'Anomalies du développement et syndromes malformatifs', Centre de Génétique, FHU-TRANSLAD et Institut GIMI, CHU Dijon Bourgogne, Dijon, France., Denommé-Pichon AS; UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France., Duffourd Y; UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France., Vitobello A; UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France., Chevarin M; UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France., Straub V; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Töpf A; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., van der Kooi AJ; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Magrinelli F; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK., Rocca C; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.; Clinical Pharmacology, William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK., Hanna MG; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK., Vandrovcova J; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK., Ossowski S; Universitätsklinikum Tübingen - Institut für Medizinische Genetik und angewandte Genomik, Tübingen, Germany., Laurie S; Centro Nacional de Análisis Genómico (CNAG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Gilissen C; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Christian.gilissen@radboudumc.nl.; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Christian.gilissen@radboudumc.nl.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Feb; Vol. 32 (2), pp. 248.
Autor:
Wijngaard R; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands., Demidov G; Universitätsklinikum Tübingen - Institut für Medizinische Genetik und angewandte Genomik, Tübingen, Germany., O'Gorman L; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Corominas-Galbany J; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Yaldiz B; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Steyaert W; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Boer E; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands., Vissers LELM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands., Kamsteeg EJ; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands., Pfundt R; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Swinkels H; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., den Ouden A; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Te Paske IBAW; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., de Voer RM; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Faivre L; Centre de Référence Maladies Rares 'Anomalies du développement et syndromes malformatifs', Centre de Génétique, FHU-TRANSLAD et Institut GIMI, CHU Dijon Bourgogne, Dijon, France., Denommé-Pichon AS; UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France., Duffourd Y; UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France., Vitobello A; UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France., Chevarin M; UMR1231-Inserm, Génétique des Anomalies du développement, Université de Bourgogne Franche-Comté, Dijon, France.; Laboratoire de Génétique chromosomique et moléculaire, UF6254 Innovation en diagnostic génomique des maladies rares, Centre Hospitalier Universitaire de Dijon, Dijon, France., Straub V; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Töpf A; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., van der Kooi AJ; Department of Neurology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands., Magrinelli F; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK., Rocca C; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.; Clinical Pharmacology, William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK., Hanna MG; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK., Vandrovcova J; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK., Ossowski S; Universitätsklinikum Tübingen - Institut für Medizinische Genetik und angewandte Genomik, Tübingen, Germany., Laurie S; Centro Nacional de Análisis Genómico (CNAG), Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Gilissen C; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. Christian.gilissen@radboudumc.nl.; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Christian.gilissen@radboudumc.nl.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2024 Feb; Vol. 32 (2), pp. 200-208. Date of Electronic Publication: 2023 Oct 19.
Autor:
São José C; i3S-Instituto de Investigação e Inovação em Saúde, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal.; Doctoral Programme in Biomedicine, Faculty of Medicine, University of Porto, Porto, Portugal., Garcia-Pelaez J; i3S-Instituto de Investigação e Inovação em Saúde, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal.; Doctoral Programme in Biomedicine, Faculty of Medicine, University of Porto, Porto, Portugal., Ferreira M; i3S-Instituto de Investigação e Inovação em Saúde, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal.; Department Computer Science Faculty of Science, University of Porto, Porto, Portugal., Arrieta O; Thoracic Oncology Unit, Department of Thoracic Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico., André A; i3S-Instituto de Investigação e Inovação em Saúde, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal., Martins N; i3S-Instituto de Investigação e Inovação em Saúde, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal.; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal.; Master Programme in Molecular Medicine and Oncology, Faculty of Medicine, University of Porto, Porto, Portugal., Solís S; INCMNSZ/Instituto de Investigaciones Biomédicas, Unidad de Biología Molecular y Medicina Genómica Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, UNAM Mexico City, Mexico., Martínez-Benítez B; Pathology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, INCMNSZ Mexico City, Mexico., Ordóñez-Sánchez ML; INCMNSZ/Instituto de Investigaciones Biomédicas, Unidad de Biología Molecular y Medicina Genómica Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, UNAM Mexico City, Mexico., Rodríguez-Torres M; INCMNSZ/Instituto de Investigaciones Biomédicas, Unidad de Biología Molecular y Medicina Genómica Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, UNAM Mexico City, Mexico., Sommer AK; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany., Te Paske IBAW; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK.; Cambridge Experimental Cancer Medicine Centre (ECMC), CRUK Cambridge Centre, NIHR Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Tischkowitz M; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Tusié MT; INCMNSZ/Instituto de Investigaciones Biomédicas, Unidad de Biología Molecular y Medicina Genómica Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, UNAM Mexico City, Mexico., Hoogerbrugge N; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Demidov G; Institute of Medical Genetics and Applied Genomics, Tübingen, Germany., de Voer RM; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands., Laurie S; The Barcelona Institute of Science and Technology, CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona, Spain., Oliveira C; i3S-Instituto de Investigação e Inovação em Saúde, Rua Alfredo Allen, 208, 4200-135, Porto, Portugal. carlaol@i3s.up.pt.; IPATIMUP-Instituto de Patologia e Imunologia Molecular da Universidade do Porto, Porto, Portugal. carlaol@i3s.up.pt.; FMUP-Faculty of Medicine of the University of Porto, Porto, Portugal. carlaol@i3s.up.pt.
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2023 Sep; Vol. 26 (5), pp. 653-666. Date of Electronic Publication: 2023 May 30.
Autor:
Elze L; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., van der Post RS; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., Vos JR; Department of Human Genetics, Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, the Netherlands., Mensenkamp AR; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., de Hullu MSC; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., Nagtegaal ID; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., Hoogerbrugge N; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., de Voer RM; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., Ligtenberg MJL; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Jul 06; Vol. 115 (7), pp. 853-860.
Autor:
Quintana I; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Terradas M; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Mur P; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain., Te Paske IBAW; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands.; Member of SOLVE-RD ERN-GENTURIS., Peters S; Member of SOLVE-RD ERN-GENTURIS.; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn 53127, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn 53127, Germany., Spier I; Member of SOLVE-RD ERN-GENTURIS.; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn 53127, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn 53127, Germany., Steinke-Lange V; Member of SOLVE-RD ERN-GENTURIS.; Medizinische Klinik Und Poliklinik IV, Campus Innenstadt, Klinikum Der Universität München, Munich 80336, Germany.; MGZ - Medizinisch Genetisches Zentrum, Munich 80335, Germany., Maestro C; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Torrents D; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona 08034, Spain.; ICREA, Barcelona 08010, Spain., Puiggròs M; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona 08034, Spain., Royo R; Life Sciences Department, Barcelona Supercomputing Center (BSC), Barcelona 08034, Spain., Tonda R; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08028, Spain., Parra G; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08028, Spain., Piscia D; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08028, Spain., Beltrán S; CNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Barcelona 08028, Spain.; Universitat Pompeu Fabra (UPF), Barcelona 08002, Spain.; Department of Genetics, Microbiology and Statistics, School of Biology, Universitat de Barcelona (UB), Barcelona 08028, Spain., Navarro M; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain., Piñol V; Gastroenterology Unit, Hospital Universitario de Girona Dr Josep Trueta, Girona 17007, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain.; Catalan Institute of Oncology, IDIBGi, Girona 17007, Spain., Gonzalez-Abuin N; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Aiza G; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain., Sommer A; Member of SOLVE-RD ERN-GENTURIS.; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn 53127, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn 53127, Germany., van Herwaarden Y; Member of SOLVE-RD ERN-GENTURIS.; Department of Gastroenterology and Hepatology, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands., Astuti G; Member of SOLVE-RD ERN-GENTURIS.; Department of Human Genetics, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands., Holinski-Feder E; Member of SOLVE-RD ERN-GENTURIS.; Medizinische Klinik Und Poliklinik IV, Campus Innenstadt, Klinikum Der Universität München, Munich 80336, Germany.; MGZ - Medizinisch Genetisches Zentrum, Munich 80335, Germany., Hoogerbrugge N; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands.; Member of SOLVE-RD ERN-GENTURIS., de Voer RM; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, GA Nijmegen 6525, the Netherlands.; Member of SOLVE-RD ERN-GENTURIS., Aretz S; Member of SOLVE-RD ERN-GENTURIS.; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn 53127, Germany.; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn 53127, Germany., Capellá G; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain.; Member of SOLVE-RD ERN-GENTURIS., Valle L; Hereditary Cancer Program, Catalan Institute of Oncology; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona 08908, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid 28029, Spain.; Member of SOLVE-RD ERN-GENTURIS.
Publikováno v:
Genes & diseases [Genes Dis] 2022 Dec 29; Vol. 10 (3), pp. 753-757. Date of Electronic Publication: 2022 Dec 29 (Print Publication: 2023).
Autor:
Te Paske IBAW; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Mensenkamp AR; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Neveling K; Department of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands., Hoogerbrugge N; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., Ligtenberg MJL; Department of Human Genetics, Department of Pathology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands., De Voer RM; Department of Human Genetics, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands. Electronic address: Richarda.devoer@radboudumc.nl.
Publikováno v:
Gastroenterology [Gastroenterology] 2022 Dec; Vol. 163 (6), pp. 1691-1694.e7. Date of Electronic Publication: 2022 Aug 28.